KR102524746B1 - How to make herbal composition for improving acne - Google Patents
How to make herbal composition for improving acne Download PDFInfo
- Publication number
- KR102524746B1 KR102524746B1 KR1020230029624A KR20230029624A KR102524746B1 KR 102524746 B1 KR102524746 B1 KR 102524746B1 KR 1020230029624 A KR1020230029624 A KR 1020230029624A KR 20230029624 A KR20230029624 A KR 20230029624A KR 102524746 B1 KR102524746 B1 KR 102524746B1
- Authority
- KR
- South Korea
- Prior art keywords
- raw material
- extract
- herbal composition
- root
- acne
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 206010000496 acne Diseases 0.000 title claims abstract description 47
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 46
- 239000002994 raw material Substances 0.000 claims abstract description 69
- 239000000284 extract Substances 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000000605 extraction Methods 0.000 claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims abstract description 5
- 238000007710 freezing Methods 0.000 claims abstract description 4
- 230000008014 freezing Effects 0.000 claims abstract description 4
- 239000002537 cosmetic Substances 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 14
- 235000004032 Centella asiatica Nutrition 0.000 claims description 11
- 244000146462 Centella asiatica Species 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 235000003373 curcuma longa Nutrition 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 241001673966 Magnolia officinalis Species 0.000 claims description 7
- 244000131360 Morinda citrifolia Species 0.000 claims description 7
- 239000001215 curcuma longa l. root Substances 0.000 claims description 7
- 235000017524 noni Nutrition 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 241000218176 Corydalis Species 0.000 claims description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241000759833 Cornus officinalis Species 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 244000241838 Lycium barbarum Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 244000061520 Angelica archangelica Species 0.000 claims description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 2
- 244000020518 Carthamus tinctorius Species 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 2
- 240000000513 Santalum album Species 0.000 claims description 2
- 235000008632 Santalum album Nutrition 0.000 claims description 2
- 240000006394 Sorghum bicolor Species 0.000 claims 2
- 235000015701 Artemisia arbuscula Nutrition 0.000 claims 1
- 235000002657 Artemisia tridentata Nutrition 0.000 claims 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims 1
- 240000006891 Artemisia vulgaris Species 0.000 claims 1
- 244000004281 Eucalyptus maculata Species 0.000 claims 1
- 210000003056 antler Anatomy 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 13
- 238000002360 preparation method Methods 0.000 abstract description 6
- 238000000227 grinding Methods 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- -1 pack Substances 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000003780 hair follicle Anatomy 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- 210000002374 sebum Anatomy 0.000 description 7
- 241000186427 Cutibacterium acnes Species 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 210000001732 sebaceous gland Anatomy 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 244000163122 Curcuma domestica Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000218378 Magnolia Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000012676 herbal extract Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- IRZTUXPRIUZXMP-UHFFFAOYSA-N rubiadin Chemical compound C1=CC=C2C(=O)C3=C(O)C(C)=C(O)C=C3C(=O)C2=C1 IRZTUXPRIUZXMP-UHFFFAOYSA-N 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 3
- 229940107131 ginseng root Drugs 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000014375 Curcuma Nutrition 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000004283 Sodium sorbate Substances 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 2
- 235000019250 sodium sorbate Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000272171 Scolopacidae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000009736 adult acne Diseases 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229940102465 ginger root Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
- A61K36/505—Corydalis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 여드름 개선용 한방조성물 제조방법에 관한 것으로, 보다 상세하게는 한방조성물을 포함하는 혼합추출물을 이용하여 여드름 피부에 효과가 있는 유효성분이 함유된 여드름 개선용 한방조성물 제조방법에 관한 것이다.The present invention relates to a method for manufacturing an herbal composition for improving acne, and more particularly, to a method for manufacturing an herbal composition for improving acne containing an active ingredient effective for acne skin using a mixed extract containing the herbal composition.
여드름은 얼굴, 가슴, 어깨 부위 등에 면모, 농포, 구진, 결절 등의 형태로 나타나는 다형성 피부질환으로, 2차 성숙이 있는 청소년기에 주로 발병한다. 11세에서 30세 사이에 약 80%가 발병하고, 30대 이후에서도 약 6%의 환자가 있는 것으로 보고되었으나 최근 들어 스트레스에 의한 성인 여드름의 발병 비율이 높아지고 있다. 이 질환은 환자에게 불쾌감을 주며 흉터 및 피부착색으로 인한 미관 손상을 일으킬 수 있다. 이에 따라 여드름 예방 및 치료에 대한 관심이 고조되고 있다.Acne is a polymorphic skin disease that appears in the form of cotton wool, pustules, papules, and nodules on the face, chest, and shoulders, and mainly occurs during adolescence with secondary maturation. It has been reported that about 80% of cases occur between the ages of 11 and 30, and about 6% of patients after the age of 30 have been reported, but recently, the incidence of adult acne due to stress is increasing. This disease is unpleasant to the patient and can cause aesthetic damage due to scarring and skin pigmentation. Accordingly, interest in the prevention and treatment of acne is increasing.
여드름의 발생의 정확한 원인은 밝혀지지 않았으며 생리적 및 환경적 측면에서 다양한 병인을 가지고 있기 때문에, 다양한 유형으로 발병하는 여드름에 대한 알맞은 치료에는 어려움이 있다. 일반적으로 피지선에서의 과도한 피지분비, 호르몬 불균형, 유전적 소질, 비정상적인 모낭 내 이상각화 및 Propionibacterium acnes의 증식 및 염증 반응 등에 의한 복합적인 요인들이 원인으로 알려져 있으며(Farrar, M. D. and Ingham, E. Acne: Clin. Dermatol. 2004. 22: 380-384; Kligman, A. M. J. Invest. Dermatol. 1974. 62: 268-287) 이에 따라 여드름을 치료하기 위한 기본적인 방법으로 모낭 각화로 인한 형질 변화 교정, 피지선의 활동성을 감소, 여드름 유발 주요 균주에 대한 항균작용, 피부 항염작용 등이 적용되고 있다.Since the exact cause of the occurrence of acne has not been identified and has various etiologies in terms of physiological and environmental aspects, it is difficult to appropriately treat acne that occurs in various types. In general, complex factors such as excessive sebum secretion from the sebaceous glands, hormonal imbalance, genetic predisposition, abnormal keratosis in the hair follicle, proliferation of Propionibacterium acnes, and inflammatory reactions are known to be the causes (Farrar, M. D. and Ingham, E. Acne: Clin. Dermatol. 2004. 22: 380-384; Kligman, A. M. J. Invest. Dermatol. 1974. 62: 268-287) Accordingly, as a basic method for treating acne, correcting the change in character due to keratinization of the hair follicle and reducing the activity of the sebaceous gland , antibacterial action against major strains causing acne, and skin anti-inflammatory action are applied.
정상 피부에는 호기성 세균인 Staphylococci, Micrococci 와 혐기성 세균인 Propionibacterium 속에 속하는 균등이 상주하고 있으며 이들 균주들의 활성에 의하여 여드름이 발생하게 될 수 있다. 특히 지방 친화를 지니는 혐기성 균주인 Propionibacterium acnes가 여드름의 주요 원인균으로 지목되고 있다(Burkhart CG et al., Postgrad. Med. J. 1999 75: 328). P. acnes는 남성호르몬인 androgen이나 다른 요인에 의해 생성된 피지의 트리글리세라이드(triglycerides)를 가수분해한 후 지방분해효소 (lipase)와 화학주성인자의 분비를 통해 유리지방산을 생성하며 염증 반응을 일으킨다. 염증 반응이 진행됨에 따라 모낭 세포의 파괴가 나타나며 최종적으로 진피까지 염증 반응이 진행되게 된다. 또한 염증이 생긴 이후에 다른 균에 의한 2차 감염이 일어날 수 있다.Staphylococci and Micrococci, which are aerobic bacteria, and equivalents belonging to the genus Propionibacterium, which are anaerobic bacteria, reside on normal skin, and acne may occur due to the activity of these strains. In particular, Propionibacterium acnes, an anaerobic strain with lipophilicity, is pointed out as the main causative agent of acne (Burkhart CG et al., Postgrad. Med. J. 1999 75: 328). P. acnes hydrolyzes triglycerides of sebum produced by the male hormone androgen or other factors, then produces free fatty acids through the secretion of lipase and chemoattractant factors, causing an inflammatory response. . As the inflammatory reaction progresses, hair follicle cells are destroyed, and finally, the inflammatory reaction progresses to the dermis. In addition, secondary infection by other bacteria may occur after inflammation occurs.
여드름의 또다른 원인 중 하나인 피지선의 발달은 제 2차 성징의 시기에 급속하게 이루어진다. 피지선의 발달로 인하여 분비 기능이 왕성해지면 모낭 내에 피지가 고여 발진이 원인이 되며 된다. 또한 정체된 피지가 모낭을 막아 공기의 순환을 차단하여 P. acnes 등 혐기성 세균의 증식을 돕게 된다.The development of sebaceous glands, which is another cause of acne, occurs rapidly during the period of secondary sexual characteristics. When the secretion function becomes active due to the development of the sebaceous gland, sebum accumulates in the hair follicle and causes a rash. In addition, stagnant sebum blocks hair follicles and blocks air circulation, helping the growth of anaerobic bacteria such as P. acnes.
모낭 각화는 모낭의 끝쪽인 모유두에서 일어나기 쉬우며 두꺼워진 각층이 모낭 내에 박리되어 모유두의 폐쇄가 일어나고 이것이 면포를 형성하게 된다. 모낭공이나 피지선의 개구부가 각질에서 막히거나 좁아지게 되면 정상 적인 피지의 배출이 억제되고 모유두에서 피지가 정체하게 된다. 그 결과로서 여드름 관련 혐기성 세균의 증식 이 증가하고, 그 생산물질이 모유두의 상피세포를 자극하여 더욱 각질이 항진된다(백혜연, 숙명여자대학교 석사 학위 논문, 향장미용, 2009. pp 7).Hair follicle keratinization easily occurs in the dermal papilla, which is the end of the hair follicle, and the thickened keratin layer is peeled off in the hair follicle, resulting in closure of the dermal papilla, which forms a comedone. When the pores of the hair follicle or the opening of the sebaceous gland are blocked or narrowed by keratin, the normal discharge of sebum is suppressed and sebum stagnates in the dermal papilla. As a result, the proliferation of acne-related anaerobic bacteria increases, and the product stimulates the epithelial cells of the dermal papilla, resulting in more exfoliation (Baek Hye-yeon, Sookmyung Women's University master's thesis, Cosmetics, 2009. pp 7).
현재까지 제안된 여드름 치료 방법으로는 남성호르몬 억제제인 에스트로겐 등의 여성호르몬이나 항남성 호르몬 제를 사용하여 피지분비를 조절하는 방법, 살리실산이나 비타민A 유도체인 레티노익산 제제를 이용한 모공의 각 질을 제거하는 방법 등이 있으나 염증을 억제하기 위한 항염제 또는 세균감염을 억제하기 위한 항생물질 적용 방법이 가장 보편적으로 사용되고 있다. 그러나 테트라사이클린(tetracycline), 에리스로마이신(erythromycin), 크린다마이신(clindamycin) 등 기존의 항생물질을 사용하는 경우 내성균의 출현이나 조직, 장기 손상, 과민반응 등과 같은 부작용이 큰 문제로 대두되고 있다. 이에 따라 독성이 적어 부작용을 줄일 수 있는 천연 유래 물질을 사용하여, 여드름 치료를 위한 항균 및 항염증에 대한 연구가 필요한 실정이다.Acne treatment methods proposed so far include controlling sebum secretion using female hormones such as estrogen, an inhibitor of male hormones, or anti-androgenic agents, and removing dead skin cells using salicylic acid or retinoic acid, a vitamin A derivative. However, anti-inflammatory agents for suppressing inflammation or antibiotics for suppressing bacterial infection are most commonly used. However, when using conventional antibiotics such as tetracycline, erythromycin, and clindamycin, side effects such as the emergence of resistant bacteria, tissue and organ damage, and hypersensitivity reactions have emerged as a major problem. Accordingly, there is a need for research on antibacterial and anti-inflammatory properties for the treatment of acne by using natural substances that are less toxic and can reduce side effects.
본 발명의 목적은 여드름 개선용 한방조성물 제조방법을 제공하기 위한 것이다.An object of the present invention is to provide a method for preparing an herbal composition for improving acne.
또한, 본 발명의 다른 목적은 한방조성물을 포함하는 혼합추출물을 이용하여 여드름 피부에 효과가 있는 유효성분이 함유된 여드름 개선용 한방조성물 제조방법을 제공하기 위함이다.In addition, another object of the present invention is to provide a method for preparing a herbal composition for improving acne containing active ingredients effective for acne skin by using a mixed extract containing the herbal composition.
본 발명의 일측면에 따르면 여드름 개선용 한방조성물의 제조방법에 있어서, (a) 강황 뿌리, 목련 수피, 고삼 뿌리 및 병풀 전초 중 선택된 1종 또는 2종 이상을 혼합한 제 1원재료 : 현호색, 선학초, 두충, 속단, 녹용, 홍화인, 토사자, 숙지황, 별갑, 산수유, 구기자, 감초, 당귀, 갈근, 강진향, 합환피, 산두근 및 괴화 중 선택된 1종 또는 2종 이상을 혼합한 제 2원재료 = 2.3~3.5 : 1.3~1.8의 중량비로 혼합된 원재료를 준비하는 원재료 준비단계; (b) 상기 원재료를 -200℃ 내지 -50℃의 온도에서 동결하여 평균입도 10~100mesh의 크기로 분쇄하는 원재료 분쇄단계; (c) 상기 분쇄한 원재료를 50℃ 내지 65℃의 온도에서 10시간 내지 15시간 동안 건조하는 건조단계; 및 (d) 상기 건조가 완료된 원재료를 추출하는 추출단계;를 포함한다.According to one aspect of the present invention, in the method of manufacturing an herbal composition for improving acne, (a) a first raw material obtained by mixing one or two or more selected from turmeric root, magnolia bark, sorghum root, and centella asiatica root: , Eucommia, Sokdan, Deer Antler, Safflower In, Tosaja, Sukjihwang, Tortoiseshell, Cornus officinalis, Wolfberry, Licorice, Angelica, Ginger root, Gangjinhyang, Hwanpi, Sandpiper, and Goehwa selected as the second raw material. = 2.3~3.5: raw material preparation step of preparing mixed raw materials at a weight ratio of 1.3~1.8; (b) a raw material pulverization step of freezing the raw material at a temperature of -200 ° C to -50 ° C and pulverizing the raw material to an average particle size of 10 to 100 mesh; (c) a drying step of drying the pulverized raw material at a temperature of 50° C. to 65° C. for 10 to 15 hours; and (d) an extraction step of extracting the dried raw material.
상기 제 1원재료는 강황 뿌리 : 목련 수피 : 고삼 뿌리 : 병풀 전초 = 1.0 : 1.2~1.5 : 0.8~1.3 : 1.0~1.5의 중량비로 혼합하여 사용할 수 있다.The first raw material may be mixed and used in a weight ratio of turmeric root: magnolia bark: ginseng root: centella asiatica = 1.0: 1.2-1.5: 0.8-1.3: 1.0-1.5.
상기 제 2원재료는 노니 부정근 추출물 : 어성초 추출물 = 0.8~2.1 : 1.3~2.5의 중량비로 혼합한 추출물에 10시간 내지 15시간동안 침지시켜 사용할 수 있다.The second raw material may be used by immersing in an extract mixed in a weight ratio of Noni adventitious root extract: Eoseongcho extract = 0.8-2.1: 1.3-2.5 for 10 to 15 hours.
상기 (d) 추출단계는 상기 건조가 완료된 원재료 및 용매를 교반기에 넣고 상온(25±2℃)에서 150rpm 내지 200rpm으로 12시간 내지 24시간동안 상온 교반 추출하는 과정을 3회 반복하여 추출물을 얻는 1차 추출단계; 상기 건조가 완료된 원재료 및 용매를 저온고압추출기에 넣고 7.0bar 내지 8.5bar의 압력에서 1시간 내지 3시간동안 추출하는 과정을 3회 반복하여 추출물을 얻는 2차 추출단계; 를 포함하고, 상기 1차 추출단계 추출물 : 2차 추출단계 추출물 = 0.5~0.8 : 1.3~1.5의 중량비로 혼합하여 사용할 수 있다.The (d) extraction step is to obtain an extract by putting the dried raw materials and solvent into a stirrer and repeating the process of stirring and extracting at room temperature (25 ± 2 ° C) at 150 rpm to 200 rpm for 12 to 24 hours three times to obtain an extract. Tea extraction step; A secondary extraction step of obtaining an extract by putting the dried raw materials and solvent into a low-temperature and high-pressure extractor and repeating the process of extracting for 1 hour to 3 hours at a pressure of 7.0 bar to 8.5 bar three times; Including, the first extraction step extract: the second extraction step extract = 0.5 ~ 0.8: can be used by mixing in a weight ratio of 1.3 ~ 1.5.
상기 한방조성물은 약제학적 조성물, 화장료 조성물 및 식품조성물 중 어느 하나이상으로 제품화될 수 있다.The herbal composition may be commercialized as any one or more of pharmaceutical compositions, cosmetic compositions, and food compositions.
이상 살펴본 바와 같은 본 발명에 따르면, 여드름 개선용 한방조성물 제조방법을 제공할 수 있다.According to the present invention as described above, it is possible to provide a method for manufacturing an herbal composition for improving acne.
또한, 본 발명에 따르면 한방조성물을 포함하는 혼합추출물을 이용하여 여드름 피부에 효과가 있는 유효성분이 함유된 여드름 개선용 한방조성물 제조방법을 제공할 수 있다.In addition, according to the present invention, it is possible to provide a method for preparing an herbal composition for improving acne containing an active ingredient effective for acne skin using a mixed extract containing an herbal composition.
또한, 본 발명에 따르면 여드름 개선용 한방조성물 제조방법으로 제조된 한방조성물은 약품, 화장품 및 식품 등으로 제품화될 수 있다.In addition, according to the present invention, the herbal composition prepared by the manufacturing method of the herbal composition for improving acne can be commercialized as medicines, cosmetics, and foods.
도 1은 본 발명의 여드름 개선용 한방조성물의 제조방법의 제조공정도이다.
도 2는 섬유아세포증식 촉진 활성 실험 결과이다.1 is a manufacturing process diagram of a manufacturing method of an herbal composition for improving acne of the present invention.
2 is a test result of fibroblast proliferation promoting activity.
기타 실시예들의 구체적인 사항들은 상세한 설명 및 도면들에 포함되어 있다.Details of other embodiments are included in the detailed description and drawings.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있으며, 이하의 설명에서 달리 명시되지 않는 한, 본 발명에 성분, 반응 조건, 성분의 함량을 표현하는 모든 숫자, 값 및/또는 표현은, 이러한 숫자들이 본질적으로 다른 것들 중에서 이러한 값을 얻는 데 발생하는 측정의 다양한 불확실성이 반영된 근사치들이므로, 모든 경우 "약"이라는 용어에 의해 수식되는 것으로 이해되어야 한다. 또한, 본 기재에서 수치범위가 개시되는 경우, 이러한 범위는 연속적이며, 달리 지적되지 않는 한 이러한 범위의 최소값으로부터 최대값이 포함된 상기 최대값까지의 모든 값을 포함한다. 더 나아가, 이러한 범위가 정수를 지칭하는 경우, 달리 지적되지 않는 한 최소값으로부터 최대값이 포함된 상기 최대값까지를 포함하는 모든 정수가 포함된다Advantages and features of the present invention, and methods of achieving them, will become clear with reference to the detailed description of the following embodiments taken in conjunction with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below, but may be implemented in various different forms, and unless otherwise specified in the following description, components, reaction conditions, and content of components are expressed in the present invention. All numbers, values and/or expressions are to be understood as being qualified in all cases by the term "about" as such numbers are inherently approximations that reflect, among other things, various uncertainties of measurement that arise in obtaining such values. . Also, when numerical ranges are disclosed herein, such ranges are contiguous and include all values from the minimum value of such range to the maximum value inclusive, unless otherwise indicated. Furthermore, where such a range refers to an integer, all integers inclusive from the minimum value to the maximum value inclusive are included unless otherwise indicated.
또한, 본 발명에서 범위가 변수에 대해 기재되는 경우, 상기 변수는 상기 범위의 기재된 종료점들을 포함하는 기재된 범위 내의 모든 값들을 포함하는 것으로 이해될 것이다. 예를 들면, "5 내지 10"의 범위는 5, 6, 7, 8, 9, 및 10의 값들뿐만 아니라 6 내지 10, 7 내지 10, 6 내지 9, 7 내지 9 등의 임의의 하위 범위를 포함하고, 5.5, 6.5, 7.5, 5.5 내지 8.5 및 6.5 내지 9 등과 같은 기재된 범위의 범주에 타당한 정수들 사이의 임의의 값도 포함하는 것으로 이해될 것이다. 예를 들면, "10% 내지 30%"의 범위는 10%, 11%, 12%, 13% 등의 값들과 30%까지를 포함하는 모든 정수들뿐 만 아니라 10% 내지 15%, 12% 내지 18%, 20% 내지 30% 등의 임의의 하위 범위를 포함하고, 10.5%, 15.5%, 25.5% 등과 같이 기재된 범위의 범주 내의 타당한 정수들 사이의 임의의 값도 포함하는 것으로 이해될 것이다.Further, in the present invention, where ranges are stated for a variable, it will be understood that the variable includes all values within the stated range inclusive of the stated endpoints of the range. For example, a range of "5 to 10" includes values of 5, 6, 7, 8, 9, and 10, as well as any subrange of 6 to 10, 7 to 10, 6 to 9, 7 to 9, and the like. inclusive, as well as any value between integers that fall within the scope of the stated range, such as 5.5, 6.5, 7.5, 5.5 to 8.5 and 6.5 to 9, and the like. For example, a range of "10% to 30%" may range from 10% to 15%, 12% to 15%, as well as values such as 10%, 11%, 12%, 13%, and all integers up to and including 30%. It will be understood to include any sub-range, such as 18%, 20% to 30%, and the like, as well as any value between reasonable integers within the scope of the stated range, such as 10.5%, 15.5%, 25.5%, and the like.
본 발명에서 "추출물"이란 추출 대상을 물, 메탄올, 에탄올, 부탄올 등의 탄소수 1 내지 4의 저급 알콜, 메틸렌클로라이드, 에틸렌, 아세톤, 헥산, 에테르, 클로로포름, 에틸아세테이트, 부틸아세테이트, N,N-디메틸포름아미드(DMF), 디메틸설폭사이드(DMSO), 1,3-부틸렌글리콜, 프로필렌글리콜 또는 이들의 혼합 용매를 사용하여 침출하여 얻어진 추출물, 이산화탄소, 펜탄 등 초임계 추출 용매를 사용하여 얻어진 추출물 또는 그 추출물을 분획하여 얻어진 분획물을 의미하며, 추출 방법은 활성물질의 극성, 추출 정도, 보존 정도를 고려하여 냉침, 환류, 가온, 초음파 방사, 초임계 추출 등 임의의 방식을 적용할 수 있다. 분획된 추출물의 경우 상기 조추출물을 특정 용매에 현탁시킨 후 극성이 다른 용매와 혼합·정치시켜 얻은 분획물을 포함하고, 상기 조추출물을 상기 용매들을 극성이 증가 또는 감소하는 순으로 사용하여 순차적으로 분획하여 얻어진 분획물을 포함하며, 나아가 크기, 전하, 소수성, 친화성 등의 성질을 이용한 크로마토그래피에 의하여 얻어진 분획물을 포함한다. 또한 상 기 추출물의 의미에는 동결건조, 진공건조, 열풍건조, 분무건조 등의 방식으로 추출 용매가 제거된 농축된 액상 또는 고형상의 추출물이 포함될 수 있다.In the present invention, the term "extract" refers to water, methanol, ethanol, lower alcohol having 1 to 4 carbon atoms such as butanol, methylene chloride, ethylene, acetone, hexane, ether, chloroform, ethyl acetate, butyl acetate, N, N- Extracts obtained by leaching using dimethylformamide (DMF), dimethyl sulfoxide (DMSO), 1,3-butylene glycol, propylene glycol or a mixture thereof, and extracts obtained using supercritical extraction solvents such as carbon dioxide and pentane Or refers to a fraction obtained by fractionating the extract, and the extraction method may be applied by any method such as cooling, reflux, heating, ultrasonic radiation, supercritical extraction, etc. in consideration of polarity, extraction degree, and preservation degree of the active substance. In the case of fractionated extracts, including fractions obtained by suspending the crude extract in a specific solvent and then mixing and standing with solvents having different polarity, the crude extract is sequentially fractionated using the solvents in the order of increasing or decreasing polarity. and further includes fractions obtained by chromatography using properties such as size, charge, hydrophobicity, and affinity. In addition, the meaning of the extract may include a concentrated liquid or solid extract from which the extraction solvent is removed by lyophilization, vacuum drying, hot air drying, spray drying, or the like.
또한, 본 발명에서 상기 "유효성분"의 의미는 단독으로 목적하는 활성을 나타내거나 또는 그 자체는 활성이 없는 담체와 함께 활성을 나타낼 수 있는 성분을 의미한다.In addition, in the present invention, the meaning of the "active ingredient" means a component that exhibits the desired activity alone or that can exhibit activity in combination with a carrier having no activity itself.
본 발명에서 특별히 정의되지 아니한 용어는 당업계에서 통용되고 있는 의미나 사전적 의미를 따른다.Terms not specifically defined in the present invention follow the meanings or dictionary meanings commonly used in the art.
본 발명의 조성물은 그 유효성분을 용도, 제형, 배합 목적 등에 따라 여드름 개선 활성, 항산화 활성 또는 항염 증 활성을 나타낼 수 있는 한 임의의 양(유효량)으로 포함할 수 있는데, 통상적인 유효량은 조성물 전체 중량을 기준으로 할 때 0.001 중량 % 내지 15 중량 % 범위 내에서 결정될 것이다. 여기서 "유효량"이란 그 적용 대상인 포유동물 바람직하게는 사람에게서, 여드름 개선 활성, 항산화 활성 또는 항염증 활성을 나타낼 수 있는 유효성 분의 양을 말한다. 이러한 유효량은 당업자의 통상의 능력 범위 내에서 실험적으로 결정될 수 있다.The composition of the present invention may contain the active ingredient in any amount (effective amount) as long as it can exhibit acne improvement activity, antioxidant activity or anti-inflammatory activity depending on the use, formulation, blending purpose, etc., but a typical effective amount is the entire composition. On a weight basis it will be determined within the range of 0.001% to 15% by weight. Here, "effective amount" refers to the amount of an active ingredient capable of exhibiting acne-improving activity, antioxidant activity, or anti-inflammatory activity in a mammal, preferably a human, to which it is applied. Such an effective amount can be determined empirically within the ordinary skill of the skilled artisan.
본 발명은 여드름 개선용 한방조성물의 제조방법을 제공할 수 있다.The present invention can provide a method for preparing an herbal composition for improving acne.
도 1은 본 발명의 여드름 개선용 한방조성물의 제조방법의 제조공정도이다.1 is a manufacturing process diagram of a manufacturing method of an herbal composition for improving acne of the present invention.
도 1을 참고하면, 본 발명은 (a) 강황 뿌리, 목련 수피, 고삼 뿌리 및 병풀 전초 중 선택된 1종 또는 2종 이상을 혼합한 제 1원재료 : 현호색, 선학초, 두충, 속단, 녹용, 홍화인, 토사자, 숙지황, 별갑, 산수유, 구기자, 감초, 당귀, 갈근, 강진향, 합환피, 산두근 및 괴화 중 선택된 1종 또는 2종 이상을 혼합한 제 2원재료 = 2.3~3.5 : 1.3~1.8의 중량비로 혼합된 원재료를 준비하는 원재료 준비단계(S100); (b) 상기 원재료를 -200℃ 내지 -50℃의 온도에서 동결하여 평균입도 10~100mesh의 크기로 분쇄하는 원재료 분쇄단계(S200); (c) 상기 분쇄한 원재료를 50℃ 내지 65℃의 온도에서 10시간 내지 15시간 동안 건조하는 건조단계(S300); 및 (d) 상기 건조가 완료된 원재료를 추출하는 추출단계(S400);를 포함한다.Referring to FIG. 1, the present invention is (a) a first raw material mixed with one or two or more selected from turmeric root, magnolia bark, ginseng root, and centella asiatica: , Tosaja, Sukjihwang, tortoise shell, cornus officinalis, goji berry, licorice, angelica root, kangjinhyang, joint hwanpi, sandalwood, and a mixture of two or more selected raw materials = 2.3~3.5: 1.3~1.8 A raw material preparation step of preparing raw materials mixed in a weight ratio (S100); (b) a raw material crushing step (S200) of freezing the raw material at a temperature of -200 ° C to -50 ° C and pulverizing the raw material to an average particle size of 10 to 100 mesh; (c) a drying step of drying the pulverized raw material at a temperature of 50° C. to 65° C. for 10 to 15 hours (S300); and (d) an extraction step (S400) of extracting the dried raw material.
상기 제 1원재료는 강황 뿌리 : 목련 수피 : 고삼 뿌리 : 병풀 전초 = 1.0 : 1.2~1.5 : 0.8~1.3 : 1.0~1.5의 중량비로 혼합하여 사용할 수 있다.The first raw material may be mixed and used in a weight ratio of turmeric root: magnolia bark: ginseng root: centella asiatica = 1.0: 1.2-1.5: 0.8-1.3: 1.0-1.5.
상기 제 2원재료는 노니 부정근 추출물 : 어성초 추출물 = 0.8~2.1 : 1.3~2.5의 중량비로 혼합한 추출물에 10시간 내지 15시간동안 침지시켜 사용할 수 있다.The second raw material may be used by immersing in an extract mixed in a weight ratio of Noni adventitious root extract: Eoseongcho extract = 0.8-2.1: 1.3-2.5 for 10 to 15 hours.
상기 노니 부정근 추출물에는 주요성분인 루비아딘(rubiadin)이 함유되어 있는데, 상기 루비아딘은 알러지 예방 및 완화에 효과가 있고, 항산화 작용을 가지는 것으로 알려져 있다. The noni adventitious root extract contains rubiadin, which is a major component, and the rubiadin is known to be effective in preventing and alleviating allergies and to have an antioxidant action.
상기 어성초 추출물은 항균 및 소염작용이 뛰어나고, 항알러지, 항산화, 면역력 증진에도 효과가 뛰어난 것으로 알려져 있다.The Eoseongcho extract is known to have excellent antibacterial and anti-inflammatory effects, and is also effective in anti-allergy, antioxidant, and immunity enhancement.
상기 (d) 추출단계는 상기 건조가 완료된 원재료 및 용매를 교반기에 넣고 상온(25±2℃)에서 150rpm 내지 200rpm으로 12시간 내지 24시간동안 상온 교반 추출하는 과정을 3회 반복하여 추출물을 얻는 1차 추출단계; 상기 건조가 완료된 원재료 및 용매를 저온고압추출기에 넣고 7.0bar 내지 8.5bar의 압력에서 1시간 내지 3시간동안 추출하는 과정을 3회 반복하여 추출물을 얻는 2차 추출단계; 를 포함하고, 상기 1차 추출단계 추출물 : 2차 추출단계 추출물 = 0.5~0.8 : 1.3~1.5의 중량비로 혼합하여 사용할 수 있다.The (d) extraction step is to obtain an extract by putting the dried raw materials and solvent into a stirrer and repeating the process of stirring and extracting at room temperature (25 ± 2 ° C) at 150 rpm to 200 rpm for 12 to 24 hours three times to obtain an extract. Tea extraction step; A secondary extraction step of obtaining an extract by putting the dried raw materials and solvent into a low-temperature and high-pressure extractor and repeating the process of extracting for 1 hour to 3 hours at a pressure of 7.0 bar to 8.5 bar three times; Including, the first extraction step extract: the second extraction step extract = 0.5 ~ 0.8: can be used by mixing in a weight ratio of 1.3 ~ 1.5.
상기 한방조성물은 약제학적 조성물, 화장품 조성물 및 식품조성물 중 어느 하나이상으로 제품화될 수 있다.The herbal composition may be commercialized as any one or more of pharmaceutical compositions, cosmetic compositions, and food compositions.
본 발명의 조성물이 적용(처방)될 수 있는 대상은 포유동물 및 사람이며, 특히 사람인 경우가 바람직하다.Subjects to which the composition of the present invention can be applied (prescribed) are mammals and humans, particularly preferably humans.
본 발명의 조성물은 구체적인 양태에 있어서, 화장료 조성물로 파악할 수 있다. 상기 화장료 조성물은 그 유효성분을 포함하는 이외에 화장료 조성물에 통상적으로 이용되는 성분들, 예컨대, 안정화제, 용해화제, 계면활성제, 비타민, 색소 및 항료와 같은 통상적인 보조제, 및 담체를 포함할 수 있다.In a specific aspect, the composition of the present invention can be identified as a cosmetic composition. In addition to the active ingredient, the cosmetic composition may include ingredients commonly used in cosmetic compositions, such as stabilizers, solubilizers, surfactants, vitamins, conventional adjuvants such as pigments and spices, and carriers. .
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데 이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니 다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared in any formulation commonly prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing , oil, powder foundation, emulsion foundation, wax foundation and spray may be formulated, but is not limited thereto. More specifically, it may be prepared in the form of softening lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로 플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진제를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane / May contain propellants such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 구체적으로 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로 필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 등을 들 수 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizing agent or emulsifying agent is used as a carrier component, specifically water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol , 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid ester, and the like.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Star cellulose, aluminum metahydroxide, bentonite, agar or tracanth and the like may be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코 시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is surfactant-containing cleansing, as carrier components, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 화장료 조성물은 그 유효성분과 전술한 바의 담체 성분을 포함시켜 당업계에 공지된 화장료 조성물의 제조방법에 따라 제조할 수 있다.The cosmetic composition of the present invention may be prepared according to a method for preparing a cosmetic composition known in the art by including the active ingredient and the above-described carrier component.
본 발명의 조성물은 다른 구체적인 양태에 있어서 약제학적 조성물로 파악될 수 있다.The composition of the present invention can be conceived as a pharmaceutical composition in another specific aspect.
본 발명의 약제학적 조성물은 그 유효성분 이외에 약제학적으로 허용되는 담체, 부형제 등을 포함하여, 국소형 제형 예컨대 크림, 로션, 연고(반고형의 외용약), 마이크로로에멀젼, 젤, 페이스트, 경피제제(TTS)(예컨대 패치 제, 붕대 등) 등으로 제조될 수 있다.The pharmaceutical composition of the present invention includes a pharmaceutically acceptable carrier, excipient, etc. in addition to its active ingredient, and is formulated into topical formulations such as creams, lotions, ointments (semi-solid external medicines), microemulsions, gels, pastes, and transdermal preparations. (TTS) (eg patch, bandage, etc.) and the like.
상기에서 "약제학적으로 허용되는" 의미는 유효성분의 활성을 억제하지 않으면서 적용(처방) 대상이 적응가능한 이상의 독성을 지니지 않는다는 의미이다.In the above, "pharmaceutically acceptable" means that it does not inhibit the activity of the active ingredient and does not have toxicity more than is adaptable to the subject of application (prescription).
약제학적으로 허용되는 담체의 예로서는 락토스, 글루코스, 슈크로스, 전분(예컨대 옥수수 전분, 감자 전분 등), 셀룰로오스, 그것의 유도체(예컨대 나트륨 카르복시메틸 셀룰로오스, 에틸셀룰로오스, 등), 맥아, 젤라틴, 탈크, 고체 윤활제(예컨대 스테아르산, 스테아르산 마그네슘 등), 황산 칼슘, 식물성 기름(예컨대 땅콩 기름, 면실유, 참기름, 올리브유 등), 폴리올(예컨대 프로필렌 글리콜, 글리세린 등), 알긴산 등을 들 수 있으며 이러 한 담체는 본 발명의 약제학적 조성물의 제형에 따라 적당한 것을 하나 이상 선택하여 사용할 수 있다. 약제학 적으로 허용되는 적합한 담체와 제제에 대해서는 문헌[Remington's Pharmaceutical Sciences(19th ed., 199 5)]을 참조할 수 있다. 본 발명의 약제학적 조성물은 유화제(예컨대 TWEENS), 습윤제(예컨대 라우릴 황산 나트 륨), 착색제, 풍미제, 안정화제, 보존제, 물, 식염수, 인산염 완충 용액 등을 추가로 포함할 수 있다.Examples of pharmaceutically acceptable carriers include lactose, glucose, sucrose, starch (eg corn starch, potato starch, etc.), cellulose, its derivatives (eg sodium carboxymethyl cellulose, ethyl cellulose, etc.), malt, gelatin, talc, solid lubricants (eg, stearic acid, magnesium stearate, etc.), calcium sulfate, vegetable oils (eg, peanut oil, cottonseed oil, sesame oil, olive oil, etc.), polyols (eg, propylene glycol, glycerin, etc.), alginic acid, and the like; may be used by selecting one or more suitable ones according to the formulation of the pharmaceutical composition of the present invention. For suitable pharmaceutically acceptable carriers and formulations, reference may be made to Remington's Pharmaceutical Sciences (19th ed., 199 5). The pharmaceutical composition of the present invention may further include an emulsifier (eg TWEENS), a wetting agent (eg sodium lauryl sulfate), a coloring agent, a flavoring agent, a stabilizer, a preservative, water, saline, a phosphate buffer solution, and the like.
부형제도 본 발명의 약제학적 조성물의 제형에 따라 적합한 것을 선택하여 사용할 수 있는데, 예컨대 나트륨 카르복시메틸 셀룰로오스, 메틸 셀룰로오스, 히드로프로필메틸셀룰로오스, 알긴산 나트륨, 폴리비닐피롤리돈 등의 현탁제나 분산제 등을 들 수 있다.Suitable excipients may be selected and used according to the formulation of the pharmaceutical composition of the present invention, for example, suspending or dispersing agents such as sodium carboxymethyl cellulose, methyl cellulose, hydropropylmethyl cellulose, sodium alginate, and polyvinylpyrrolidone. can
본 발명의 약제학적 조성물은 그 1일 투여량이 통상 0.001 ~ 150 mg/kg 체중 범위이고, 1회 또는 수회로 나누어 투여할 수 있다. 그러나, 본 발명의 약제학적 조성물의 투여량은 투여 경로, 환자의 연령, 성별, 체중, 환자의 중증도 등의 여러 관련 인자에 비추어 결정되는 것이므로 상기 투여량은 어떠한 측면으로든 본 발명의 범위를 제한하는 것으로 이해되어서는 아니 된다.The daily dosage of the pharmaceutical composition of the present invention is usually in the range of 0.001 to 150 mg/kg body weight, and may be administered once or divided into several times. However, since the dosage of the pharmaceutical composition of the present invention is determined in light of various related factors such as the route of administration, the age, sex, weight, and severity of the patient, the dosage limits the scope of the present invention in any aspect. should not be understood as
본 발명의 조성물은 구체적인 양태에 있어서, 식품 조성물로 파악할 수 있다.In a specific aspect, the composition of the present invention can be regarded as a food composition.
본 발명의 식품 조성물에는 그 유효성분 이외에 감미제, 풍미제, 생리활성 성분, 미네랄 등이 포함될 수 있다.The food composition of the present invention may include sweeteners, flavors, physiologically active ingredients, minerals, and the like in addition to the active ingredients.
감미제는 식품이 적당한 단맛을 나게 하는 양으로 사용될 수 있으며, 천연의 것이거나 합성된 것일 수 있다. 바람직하게는 천연 감미제를 사용하는 경우인데, 천연 감미제로서는 옥수수 시럽 고형물, 꿀, 수크로오스, 프룩토 오스, 락토오스, 말토오스 등의 당 감미제를 들 수 있다.Sweeteners can be used in amounts that give the food a moderately sweet taste, and can be natural or synthetic. Preferably, natural sweeteners are used, and natural sweeteners include sugar sweeteners such as corn syrup solids, honey, sucrose, fructose, lactose, and maltose.
풍미제는 맛이나 향을 좋게 하기 위하여 사용될 수 있는데, 천연의 것과 합성된 것 모두 사용될 수 있다. 바람 직하게는 천연의 것을 사용하는 경우이다. 천연의 것을 사용할 경우에 풍미 이외에 영양 강화의 목적도 병행할 수 있다. 천연 풍미제로서는 사과, 레몬, 감귤, 포도, 딸기, 복숭아 등에서 얻어진 것이거나 녹차잎, 둥굴레, 대잎, 계피, 국화 잎, 자스민 등에서 얻어진 것일 수 있다. 또 인삼(홍삼), 죽순, 알로에 베라, 은행 등에서 얻 어진 것을 사용할 수 있다. 천연 풍미제는 액상의 농축액이나 고형상의 추출물일 수 있다. 경우에 따라서 합성 풍미제가 사용될 수 있는데, 합성 풍미제는 에스테르, 알콜, 알데하이드, 테르펜 등이 이용될 수 있다. Flavors may be used to improve taste or aroma, and both natural and synthetic flavors may be used. Preferably, it is the case of using a natural one. In case of using natural ones, in addition to flavor, the purpose of enhancing nutrition can also be combined. As a natural flavoring agent, it may be obtained from apples, lemons, tangerines, grapes, strawberries, peaches, etc., or obtained from green tea leaves, roundworms, bamboo leaves, cinnamon, chrysanthemum leaves, jasmine, and the like. Also, those obtained from ginseng (red ginseng), bamboo shoots, aloe vera, and ginkgo can be used. Natural flavors can be liquid concentrates or solid extracts. In some cases, synthetic flavors may be used, and synthetic flavors may include esters, alcohols, aldehydes, terpenes, and the like.
생리 활성 물질로서는 카테킨, 에피카테킨, 갈로가테킨, 에피갈로카테킨 등의 카테킨류나, 레티놀, 아스코르브 산, 토코페롤, 칼시페롤, 티아민, 리보플라빈 등의 비타민류 등이 사용될 수 있다. As the physiologically active substance, catechins such as catechin, epicatechin, gallocatechin, and epigallocatechin, and vitamins such as retinol, ascorbic acid, tocopherol, calciferol, thiamine, and riboflavin may be used.
미네랄로서는 칼슘, 마그네슘, 크롬, 코발트, 구리, 불소화물, 게르마늄, 요오드, 철, 리튬, 마그네슘, 망간, 몰리브덴, 인, 칼륨, 셀레늄, 규소, 나트륨, 황, 바나듐, 아연 등이 사용될 수 있다.Examples of minerals include calcium, magnesium, chromium, cobalt, copper, fluoride, germanium, iodine, iron, lithium, magnesium, manganese, molybdenum, phosphorus, potassium, selenium, silicon, sodium, sulfur, vanadium, zinc, and the like.
또한 본 발명의 식품 조성물은 상기 감미제 등 이외에도 필요에 따라 보존제, 유화제, 산미료, 점증제 등을 포함할 수 있다.In addition, the food composition of the present invention may include a preservative, an emulsifier, an acidulant, a thickener, and the like, if necessary, in addition to the sweetener.
이러한 보존제, 유화제 등은 그것이 첨가되는 용도를 달성할 수 있는 한 극미량으로 첨가되어 사용되는 것이 바람직하다. 극미량이란 수치적으로 표현할 때 식품 조성물 전체 중량을 기준으로 할 때 0.0005중량% 내지 약 0.5중량% 범위를 의미한다.These preservatives, emulsifiers, etc. are preferably added and used in very small amounts as long as the purpose to which they are added can be achieved. A trace amount means a range of 0.0005% by weight to about 0.5% by weight based on the total weight of the food composition when expressed numerically.
사용될 수 있는 보존제로서는 소듐 소르브산칼슘, 소르브산나트륨, 소르브산칼륨, 벤조산칼슘, 벤조산나트륨, 벤조산칼륨, EDTA 에틸렌디아민테트라아세트산) 등을 들 수 있다.Preservatives that may be used include sodium sorbate, sodium sorbate, potassium sorbate, calcium benzoate, sodium benzoate, potassium benzoate, EDTA (ethylenediaminetetraacetic acid) and the like.
사용될 수 있는 유화제로서는 아카시아검, 카르복시메틸셀룰로스, 잔탄검, 펙틴 등을 들 수 있다.Examples of emulsifiers that may be used include gum acacia, carboxymethylcellulose, xanthan gum, pectin, and the like.
사용될 수 있는 산미료로서는 연산, 말산, 푸마르산, 아디프산, 인산, 글루콘산, 타르타르산, 아스코르브산, 아세트산, 인산 등을 들 수 있다. 이러한 산미료는 맛을 증진시키는 목적 이외에 미생물의 증식을 억제할 목적으 로 식품 조성물이 적정 산도로 되도록 첨가될 수 있다.Acidulants that may be used include acid salt, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, phosphoric acid, and the like. Such an acidulant may be added so that the food composition has a titratable acidity for the purpose of inhibiting the growth of microorganisms in addition to the purpose of enhancing the taste.
사용될 수 있는 점증제로서는 현탁화 구현제, 침강제, 겔형성제, 팽화제 등을 들 수 있다.As thickeners that can be used, suspending agents, sedimentation agents, gel forming agents, bulking agents and the like may be mentioned.
이하 본 발명을 실시예 및 실험예를 참조하여 설명한다. 그러나 본 발명의 범위가 이러한 실시예 및 실험예에 한정되는 것은 아니다.Hereinafter, the present invention will be described with reference to Examples and Experimental Examples. However, the scope of the present invention is not limited to these Examples and Experimental Examples.
(실시 예) 한방추출물의 제조(Example) Preparation of herbal extract
제 1원재료로 강황 뿌리, 목련 수피, 고삼 뿌리 및 병풀 전초를 1.0 : 1.2 : 0.8 : 1.0의 중량비로 혼합하여 준비하고, 제 2원재료로 현호색을 선택하여 노니 부정근 추출물 : 어성초 추출물 = 0.8 : 1.3의 중량비로 혼합한 추출물에 12시간동안 침지시켜 준비한 뒤, 제 1원재료 : 제 2원재료를 2.3 : 1.3의 중량비로 혼합하여 준비하였다.As the first raw material, turmeric root, magnolia bark, sorghum root, and Centella asiatica root were mixed and prepared in a weight ratio of 1.0: 1.2: 0.8: 1.0, and corydalis was selected as the second raw material, and Noni adventitious root extract: Eoseongcho extract = 0.8: 1.3 After preparing by immersing in the extract mixed at a weight ratio for 12 hours, the first raw material: the second raw material was prepared by mixing at a weight ratio of 2.3: 1.3.
상기 혼합된 원재료를 -150℃에서 동결하여 평균입도 50mesh의 크기로 분쇄한 후 50℃에서 12시간동안 건조하였다.The mixed raw materials were frozen at -150 ° C, pulverized to an average particle size of 50 mesh, and then dried at 50 ° C for 12 hours.
건조가 완료된 원재료를 70% 에탄올과 함께 교반기에 넣고 상온(25±2℃)에서 150rpm으로 20시간동안 상온 교반 추출하는 과정을 3회 반복하여 1차 추출물을 얻고, 건조가 완료된 원재료를 70% 에탄올과 함께 저온고압추출기에 넣고 8.0bar의 압력에서 2시간동안 추출하는 과정을 3회 반복하여 2차 추출물을 얻었다. 1차 추출물 : 2차 추출물 = 0.7 : 1.5 중량비로 혼합하여 본 발명의 한방추출물을 얻었다.The dried raw material was put into a stirrer with 70% ethanol, and the process of stirring and extracting at room temperature (25±2℃) for 20 hours at 150 rpm was repeated three times to obtain the primary extract, and the dried raw material was mixed with 70% ethanol. Into a low-temperature and high-pressure extractor together with, the process of extraction for 2 hours at a pressure of 8.0 bar was repeated three times to obtain a secondary extract. The first extract: the second extract = 0.7: mixed in a weight ratio of 1.5 to obtain the herbal extract of the present invention.
(실험 예 1) 항산화 활성 (DPPH radical 소거능 측정)(Experimental Example 1) Antioxidant activity (DPPH radical scavenging ability measurement)
100% 메탄올에 DPPH를 0.1mM이 되도록 첨가하여 DPPH 용액을 제조한 후 실시예의 각 시료를 2%(w/v), 1%(w/v), 0.5%(w/v), 0.1%(w/v) 및 0.01%(w/v)이 되도록 첨가하였다. 다음 10초간 강하게 vortexing 하고 암소에서 30분 간 방치한 후에 ELISA를 이용하여 517 nm에서 흡광도를 측정한다. 항산화 활성은 순수한 물을 사용한 대조군의 흡광강도를 기준으로 DPPH radical 소거능을 백분율로 나타내었다.After preparing a DPPH solution by adding DPPH to 0.1 mM in 100% methanol, each sample in Example was 2% (w / v), 1% (w / v), 0.5% (w / v), 0.1% ( w/v) and 0.01% (w/v). After vortexing vigorously for 10 seconds and leaving it in the dark for 30 minutes, the absorbance is measured at 517 nm using ELISA. Antioxidant activity was expressed as percentage of DPPH radical scavenging ability based on the absorbance of the control group using pure water.
농도process
density
+고삼+병풀
혼합Turmeric + Magnolia
+Gosam + Centella asiatica
mix
침지Noni + Eoseongcho
immersion
상기 표 1은 상기 제 1원재료 단일 추출물, 제 2원재료 단일 추출물 보다 제 1원재료와 제 2원재료를 혼합한 추출물 즉, 실시 예에 의한 본 발명의 한방추출물이 DPPH radical 소거능이 전반적으로 높게 나타났고, 이는 항산화활성이 높음을 보여준다. 특히 혼합추출물의 0.1%(w/v)의 처리농도가 저농도에서도 93%의 높은 항산화 활성을 나타냈다.Table 1 shows that the DPPH radical scavenging activity of the extract obtained by mixing the first raw material and the second raw material, that is, the herbal extract of the present invention according to the Example, was generally higher than that of the single extract of the first raw material and the single extract of the second raw material, This shows that the antioxidant activity is high. In particular, the treatment concentration of 0.1% (w/v) of the mixed extract showed a high antioxidant activity of 93% even at a low concentration.
(실험 예 2) 여드름 개선 활성-여드름 균(Propionibacterium acnes)에 대한 항균활성 측정(Experimental Example 2) Acne improvement activity - measurement of antibacterial activity against acne bacteria (Propionibacterium acnes)
항균력 측정은 Disc diffusion assay 방법을 사용하였으며, 시험 균주인 여드름 균(Propionibacterium acnes) 10㎖의 액체배지(GAM Broth)에 접종하고 37℃에서 24시간씩 3회 계대배양하여 항균 활성 시험 균주로 사용하였다.Disc diffusion assay was used to measure antibacterial activity. Propionibacterium acnes, a test strain, was inoculated into 10 ml of liquid medium (GAM Broth) and subcultured 3 times for 24 hours at 37 ° C to be used as an antibacterial activity test strain. .
항균 활성 실험은 상기 시험 균주가 배양된 액체배지(GAM Broth)에 Paper Disc를 삽입한 후 꺼내어 시험 균주가 배양된 액체배지로 Paper Disc를 충분히 적신 후, 증류수를 이용하여 상기 실시예의 각 시료를 2%(w/v), 1%(w/v), 0.5%(w/v) 및 0.25%(w/v) 및 0.01%(w/v)의 농도로 제작하여 상기 Paper Disc 20㎕씩 적하하였다. 다음 37℃에서 24시간 배양하고 disc 주변에 생성된 생육저해환(clearzone, cm)의 크기를 측정하여 항균활성을 분석하였다. 음성대조군으로는 추출물 희석 시 사용한 증류수를 사용하였다.In the antibacterial activity test, the paper disc was inserted into the liquid medium (GAM Broth) in which the test strain was cultured, taken out, sufficiently wetted with the liquid medium in which the test strain was cultured, and each sample of the above example was 2 times using distilled water. 20 μl of the Paper Discs were added at concentrations of % (w/v), 1% (w/v), 0.5% (w/v), 0.25% (w/v), and 0.01% (w/v). did After incubation at 37 ° C. for 24 hours, the antibacterial activity was analyzed by measuring the size of the growth inhibition ring (clearzone, cm) generated around the disc. Distilled water used for diluting the extract was used as a negative control group.
(%)density
(%)
+고삼+병풀
혼합Turmeric + Magnolia
+Gosam + Centella asiatica
mix
침지Noni + Eoseongcho
상기 표 2의 결과를 살펴보면 상기 제 1원재료 단일 추출물, 제 2원재료 단일 추출물 보다 제 1원재료와 제 2원재료를 혼합한 추출물 즉, 실시 예에 의한 본 발명의 한방추출물이 항균활성이 우수함을 나타내고 있다.Looking at the results of Table 2, the extract obtained by mixing the first raw material and the second raw material, that is, the herbal extract of the present invention according to the embodiment has excellent antibacterial activity compared to the single extract of the first raw material and the single extract of the second raw material. .
(실험 예 3) 섬유아세포 증식 촉진 활성 실험 (MTT assay)(Experimental Example 3) Fibroblast proliferation promoting activity test (MTT assay)
섬유아세포주를 0% FBS를 함유하는 DMEM 배지가 포함된 96 well plate에 1 Х 10 4 [0070] cells/well씩 동일하게 hemocytometer를 이용하여 계수한 후 분주하고 48시간 배양하였다. 다음 실시예의 한방조성물을 0.1%(w/v), 0.05%(w/v), 0.01%(w/v), 0.005%(w/v), 0.001%(w/v)로 함유된 FBS-free DMEM으로 교체하여 24시간 더 배양(시료 희석은 배양배지로 희석) 하였다. 배양 후 3-,4,5-di methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide용액 (2.5 mg/ml)을 50㎕ 첨가하고 3시간 추가 배양하고 세포 배양액을 전부 제거하였다. 200㎕의 dimethyl sulfoxide를 각 well 당 1ml씩 처리하여 교반한 후 100㎕씩을 96 well에서 취하여 EnzymeLinked Immunosorbent Assay (ELISA)로 570 nm에서 흡광도를 측정하였다.Fibroblasts were counted using a hemocytometer at 1 Х 10 4 cells/well in the same way in a 96-well plate containing DMEM medium containing 0% FBS, then aliquoted and cultured for 48 hours. The herbal composition of the following examples was 0.1% (w / v), 0.05% (w / v), 0.01% (w / v), 0.005% (w / v), 0.001% (w / v) FBS- It was replaced with free DMEM and further cultured for 24 hours (sample dilution was diluted with culture medium). After incubation, 50 μl of 3-,4,5-di methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide solution (2.5 mg/ml) was added, followed by further incubation for 3 hours, and the cell culture medium was completely removed. 200 μl of dimethyl sulfoxide was treated with 1 ml per well, stirred, and 100 μl was taken from 96 wells, and absorbance was measured at 570 nm by EnzymeLinked Immunosorbent Assay (ELISA).
결과를 하기의 도 2에 나타내었다. 도 2는 섬유아세포증식 촉진 활성 실험 결과이다. 도 2를 참고하면, 대부분의 처리농도에 비례하여 섬유아세포가 증식함을 알 수 있다.The results are shown in Figure 2 below. 2 is a test result of fibroblast proliferation promoting activity. Referring to Figure 2, it can be seen that most of the fibroblasts proliferated in proportion to the treatment concentration.
(실험 예 4) 피부 트러블 개선 평가(Experimental Example 4) Skin trouble improvement evaluation
피부 여드름 트러블에 대한 개선 효과를 평가하기 위하여 20명의 남녀(남자 10명, 여자 10명/10대 5명, 20대 5명, 30대 5명, 40대 5명)를 대상으로 실시 예를 통하여 제조된 한방조성물을 포함하는 화장료(로션)을 2주동안 트러블이 발생 된 피부에 도포하여 하기 표 3의 평가기준으로 관능평가를 진행하였다.In order to evaluate the improvement effect on skin acne trouble, 20 men and women (10 men, 10 women / 5 teenagers, 5 people in their 20s, 5 people in their 30s, 5 people in their 40s) were tested through an example. Cosmetics (lotions) containing the prepared herbal composition were applied to the troubled skin for 2 weeks, and sensory evaluation was performed according to the evaluation criteria in Table 3 below.
평가기준은 100점 만점으로 하여, 피험자의 평균 값으로 평가하였다.The evaluation criterion was evaluated as the average value of the subjects with a perfect score of 100 points.
상기 표 3의 결과를 살펴보면, 실시 예에 의하여 제조된 본 발명의 한방조성물을 포함하는 화장료(로션)에 대하여 전체적으로 만족도, 여드름 개선 정도, 보습력, 상처 개선도의 평가에서 우수한 평가를 받았음을 확인할 수 있었다.Looking at the results of Table 3, it can be confirmed that the cosmetics (lotions) containing the herbal composition of the present invention prepared according to the examples received excellent evaluation in the overall satisfaction, acne improvement degree, moisturizing power, and wound improvement evaluation. there was.
따라서, 본 발명의 한방 조성물의 제조방법으로 제조된 한방조성물은 여러가지 한방재료를 포함하여 제조되어 항염증 및 항산화효과가 향상되어 여드름 피부를 개선할 수 있는 효과를 제공할 수 있다. Therefore, the herbal composition prepared by the manufacturing method of the herbal composition of the present invention can provide an effect of improving acne skin by improving anti-inflammatory and antioxidant effects by including various herbal ingredients.
본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허청구의 범위에 의하여 나타내어지며, 특허청구의 범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.Those skilled in the art to which the present invention pertains will understand that the present invention can be embodied in other specific forms without changing its technical spirit or essential features. Therefore, the embodiments described above should be understood as illustrative in all respects and not limiting. The scope of the present invention is indicated by the claims to be described later rather than the detailed description above, and all changes or modifications derived from the meaning and scope of the claims and equivalent concepts thereof are included in the scope of the present invention. should be interpreted
S100 : 원재료 준비단계
S200 : 원재료 분쇄단계
S300 : 건조단계
S400 : 추출단계S100: raw material preparation step
S200: raw material crushing step
S300: Drying step
S400: Extraction step
Claims (5)
(a) 강황 뿌리, 목련 수피, 고삼 뿌리 및 병풀 전초 중 선택된 1종 또는 2종 이상을 혼합한 제 1원재료 : 현호색, 선학초, 두충, 속단, 녹용, 홍화인, 토사자, 숙지황, 별갑, 산수유, 구기자, 감초, 당귀, 갈근, 강진향, 합환피, 산두근 및 괴화 중 선택된 1종 또는 2종 이상을 혼합한 제 2원재료 = 2.3~3.5 : 1.3~1.8의 중량비로 혼합된 원재료를 준비하는 원재료 준비단계;
(b) 상기 원재료를 -200℃ 내지 -50℃의 온도에서 동결하여 평균입도 10~100mesh의 크기로 분쇄하는 원재료 분쇄단계;
(c) 상기 분쇄한 원재료를 50℃ 내지 65℃의 온도에서 10시간 내지 15시간 동안 건조하는 건조단계; 및
(d) 상기 건조가 완료된 원재료를 추출하는 추출단계;를 포함하는 여드름 개선용 한방조성물 제조방법.In the manufacturing method of the herbal composition for improving acne,
(a) First raw material that is a mixture of one or more selected from among turmeric root, magnolia bark, sorghum root and centella asiatica root: corydalis, sagebrush, eucalyptus, sokdan, antler, safflower, tosaja, sukjihwang, tortoiseshell, cornus officinalis, Goji berry, licorice, angelica root, kangjinhyang, haphwan husk, sandalwood, and a mixture of two or more selected raw materials = 2.3~3.5: raw materials to prepare mixed raw materials at a weight ratio of 1.3~1.8 preparatory stage;
(b) a raw material pulverization step of freezing the raw material at a temperature of -200 ° C to -50 ° C and pulverizing the raw material to an average particle size of 10 to 100 mesh;
(c) a drying step of drying the pulverized raw material at a temperature of 50° C. to 65° C. for 10 to 15 hours; and
Method for manufacturing an herbal composition for improving acne, comprising: (d) an extraction step of extracting the dried raw material.
상기 제 1원재료는,
강황 뿌리 : 목련 수피 : 고삼 뿌리 : 병풀 전초 = 1.0 : 1.2~1.5 : 0.8~1.3 : 1.0~1.5의 중량비로 혼합하여 사용하는 것을 특징으로 하는 여드름 개선용 한방조성물 제조방법.According to claim 1,
The first raw material,
Turmeric root: magnolia bark: sorghum root: Centella asiatica root = 1.0: 1.2-1.5: 0.8-1.3: 1.0-1.5 A method for producing an herbal composition for improving acne, characterized in that it is mixed and used in a weight ratio.
상기 제 2원재료는,
노니 부정근 추출물 : 어성초 추출물 = 0.8~2.1 : 1.3~2.5의 중량비로 혼합한 추출물에 10시간 내지 15시간동안 침지시켜 사용하는 것을 특징으로 하는 여드름 개선용 한방조성물 제조방법.According to claim 1,
The second raw material,
Noni adventitious root extract: Eoseongcho extract = 0.8 ~ 2.1: A method for producing an herbal composition for improving acne, characterized in that it is used by immersing for 10 to 15 hours in an extract mixed at a weight ratio of 1.3 to 2.5.
상기 (d) 추출단계는,
상기 건조가 완료된 원재료 및 용매를 교반기에 넣고 상온(25±2℃)에서 150rpm 내지 200rpm으로 12시간 내지 24시간동안 상온 교반 추출하는 과정을 3회 반복하여 추출물을 얻는 1차 추출단계;
상기 건조가 완료된 원재료 및 용매를 저온고압추출기에 넣고 7.0bar 내지 8.5bar의 압력에서 1시간 내지 3시간동안 추출하는 과정을 3회 반복하여 추출물을 얻는 2차 추출단계; 를 포함하고,
상기 1차 추출단계 추출물 : 2차 추출단계 추출물 = 0.5~0.8 : 1.3~1.5의 중량비로 혼합하여 사용하는 것을 특징으로 하는 여드름 개선용 한방조성물 제조방법.According to claim 1,
The (d) extraction step,
A primary extraction step of obtaining an extract by putting the dried raw materials and solvent into a stirrer and repeating the process of stirring and extracting at room temperature (25 ± 2 ° C) for 12 to 24 hours at 150 rpm to 200 rpm three times to obtain an extract;
A secondary extraction step of obtaining an extract by putting the dried raw materials and solvent into a low-temperature and high-pressure extractor and repeating the process of extracting for 1 hour to 3 hours at a pressure of 7.0 bar to 8.5 bar three times; including,
The method for producing an herbal composition for improving acne, characterized in that the extract of the first extraction step: the extract of the second extraction step = 0.5 ~ 0.8: mixed in a weight ratio of 1.3 to 1.5.
상기 한방조성물은,
약제학적 조성물, 화장료 조성물 및 식품조성물 중 어느 하나이상으로 제품화될 수 있는 여드름 개선용 한방조성물 제조방법.According to claim 1,
The herbal composition,
A method for preparing an herbal composition for improving acne that can be commercialized as any one or more of pharmaceutical compositions, cosmetic compositions, and food compositions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230029624A KR102524746B1 (en) | 2023-03-07 | 2023-03-07 | How to make herbal composition for improving acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230029624A KR102524746B1 (en) | 2023-03-07 | 2023-03-07 | How to make herbal composition for improving acne |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102524746B1 true KR102524746B1 (en) | 2023-04-26 |
Family
ID=86099611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230029624A KR102524746B1 (en) | 2023-03-07 | 2023-03-07 | How to make herbal composition for improving acne |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102524746B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160001478A (en) * | 2014-06-27 | 2016-01-06 | 동신대학교산학협력단 | Composition for Improving Acne |
KR20190001628A (en) * | 2017-06-26 | 2019-01-07 | 제이앤팜유한책임회사 | Cosmetics for anti-aging or whitening of skin with ethanol extract of Crataegi fructus fruit |
-
2023
- 2023-03-07 KR KR1020230029624A patent/KR102524746B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160001478A (en) * | 2014-06-27 | 2016-01-06 | 동신대학교산학협력단 | Composition for Improving Acne |
KR20190001628A (en) * | 2017-06-26 | 2019-01-07 | 제이앤팜유한책임회사 | Cosmetics for anti-aging or whitening of skin with ethanol extract of Crataegi fructus fruit |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101835486B1 (en) | Functional composition for improving atopic dermatitis comprising plant cell fermentation nano extract and functional cosmetic comprising the same | |
KR101599763B1 (en) | Composition for Improving Acne | |
KR101810231B1 (en) | Cosmetic composition for improving acne containing propolis spicule powder | |
WO2021104276A1 (en) | Uses of fu tea extract in preparing skin-conditioning product | |
US4803069A (en) | Composition for the treatment of acne | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
KR101230277B1 (en) | Composition of External Application for Using Bamboo Sprout | |
KR101827771B1 (en) | Cosmetic composition containing Broussonetia extract for improving acne | |
KR102130571B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin and extract of Euterpe oleracea fruit | |
KR101397160B1 (en) | Cosmetic compositon for skin-irritation alleviation with Inula britannica var. chinensis, Cynanchi Radix and Lysimachia foenum-graecum Hance | |
KR101315346B1 (en) | Compositions for Improving Skin Conditions Using an Extract of Stichopus japonicus Red | |
KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
KR102257448B1 (en) | Cosmetic composition containing black kelp | |
KR20210090870A (en) | Cosmetic composition with excellent skin barrier using skin microbiome | |
KR102524746B1 (en) | How to make herbal composition for improving acne | |
KR101852510B1 (en) | Cosmetic Composition Containing Broussonetia Extract for Inhibiting Lipogenesis and Decreasing Sebum Secretion of Skin | |
KR102169463B1 (en) | Cosmetic composition for improving skin troubles | |
KR101938301B1 (en) | Anti-acne composition comprising extracts of rubus coreanus, and willow or propolis | |
KR20180017974A (en) | Cosmetic composition for preventing or treating acne comprising combined herbal extracts | |
KR20220055757A (en) | Cosmetic composition containing lemon myrtle extract and its manufacturing method | |
KR101154501B1 (en) | A composition of eliminating keratin comprising saussurea involucratae extract | |
KR102525129B1 (en) | Composition comprising fermented extracts of unripe plum and manufacturing method thereof | |
KR101479550B1 (en) | Cosmetics composition containing germinated Phaseolus radiatus, germinated Phaseolus angularis and extracts of Sophora flavescens | |
NL2029500B1 (en) | Cosmetic preparation using hedychium coronarium as an anti-aging skin care factor and preparation method thereof | |
KR100909729B1 (en) | Cosmetic composition for preventing and improving acne containing Namsil extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |